Functional positron emission tomographic studies of striatal dopaminergic activity. Changes induced by drugs and nigrostriatal degeneration.
Tedroff
J
J
Department of Neurology, University Hospital, Uppsala, Sweden.
Aquilonius
S M
SM
Hartvig
P G
PG
Långström
B
B
D000818:Animals; D000978:Antiparkinson Agents; D004295:Dihydroxyphenylalanine / Q000031:analogs & derivatives / Q000502:physiology; D004298:Dopamine / Q000502:physiology*; D006801:Humans; D007980:Levodopa; D017072:Neostriatum / Q000000981:diagnostic imaging* / Q000187:drug effects; D009410:Nerve Degeneration / Q000502:physiology; D013378:Substantia Nigra / Q000473:pathology*; D014055:Tomography, Emission-Computed
D000978:Antiparkinson Agents; C043437:fluorodopa F 18; D007980:Levodopa; D004295:Dihydroxyphenylalanine; D004298:Dopamine